Nippon India Pharma Fund - Direct - Growth

A Equity Scheme by Nippon Life India Asset Management Limited

3Y Returns (CAGR)
20.89%
Expense Ratio
0.94%

as of 01/05/2026

AUM
₹2,128.02 Cr

Qtr End: Mar 26

NAV
₹595.361

as of 03/06/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M4.07%17.30%15.39%
6M3.39%6.89%14.02%
1Y4.83%4.83%12.61%
3Y76.69%20.89%13.15%
5Y81.55%12.67%13.24%
Scheme Details
Launch Date
10/05/2004
Fund Age
22.1 years
Minimum Investment
₹5,000
Fund House
Nippon India Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions